about
Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissuesAssociation of high expression of Groβ with clinical and pathological characteristics of unfavorable prognosis in gastrointestinal stromal tumors.Molecularly Targeted Therapy of Human Hepatocellular Carcinoma Xenografts with Radio-iodinated Anti-VEGFR2 Murine-Human Chimeric FabOverexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma.Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer.High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.Overexpression of Rab27B is correlated with distant metastasis and poor prognosis in ovarian cancerEphA8 is a prognostic marker for epithelial ovarian cancer.LTBP2 is a prognostic marker in head and neck squamous cell carcinoma.Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.Clinical Significance and Prognostic Value of the Expression of LAMP3 in Oral Squamous Cell CarcinomaPotential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.Expression of β-nerve growth factor and homeobox A10 in experimental cryptorchidism treated with exogenous nerve growth factor.High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer.High expression of RAB27A and TP53 in pancreatic cancer predicts poor survivalSCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells
P50
Q35067928-F9809C00-051A-4359-90E5-9836E42984D2Q35511907-5FB33FE9-3813-4596-9573-56B146E89F39Q35662815-6F1502EC-49F0-490B-8C37-629CF38EC0D8Q35852265-92AA2647-3CAE-4C08-A772-3035BF0C3D3BQ35936126-C01AFBCA-EE27-48D2-B34F-04410EC31DF1Q36413067-BE85C548-EFEB-4DE3-983A-002F6F36BB41Q36467279-292455A2-D007-4E0D-BB73-0B2939142F2BQ36782607-E706D117-4BC2-4343-9D5C-7AE588714B5EQ37106757-8F7186D0-48DE-407F-9516-C0F740E4E0ADQ37190444-B127053B-2A58-4041-85D3-570C6E08D48DQ37564340-2CA70F0C-1844-4DD5-8B9D-26771467BEC2Q38943871-8D58D38C-E56D-42CB-833F-CD8C5FE49ADDQ42086850-E9390E97-654E-435A-9A8E-E0C7C7D11939Q42234014-25C31413-61C0-4208-96E5-6EDABE3973EFQ45811544-7D30EA49-5EE3-4925-82F0-0BB1682F958AQ54183440-E6E48623-C308-480E-A229-2AB33A13AE0CQ54296129-D073A434-8955-47EE-B3F1-41CD9A4EDEF5Q86065192-DF713428-3466-49D5-B346-E627DBBBB918Q91753105-41953632-6B5C-4D9E-952F-99BFED23BE7F
P50
description
researcher (ORCID 0000-0002-1276-5962)
@en
wetenschapper
@nl
name
Jianfei Huang
@en
Jianfei Huang
@nl
type
label
Jianfei Huang
@en
Jianfei Huang
@nl
prefLabel
Jianfei Huang
@en
Jianfei Huang
@nl
P31
P496
0000-0002-1276-5962